Acute Stroke Clinical Trial
— RICH-2Official title:
The Safety and Efficacy of Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage: A Multicenter, Randomized, Controlled Study
Intracerebral hemorrhage (ICH) results from the rupture of small vessels damaged by chronic hypertension, amyloid angiopathy or other disease. Currently, ICH has been a devastating type of stroke that lacking effective therapy. Remote ischemic conditioning (RIC), a systematically protective strategy, has been found to have neuroprotective effects by in patients with ischemic stroke. In addition, animal studies show that RIC is safe in ICH model and it could accelerate the absorption of hematoma. In a previous clinical study (RICH-1), RIC have been found to be safe and well-tolerated in patients with ICH. Therefore, the investigators plan to undertake this study to further evaluate the safety and efficacy of RIC in patients with ICH. The investigators hypothesize that treatment with RIC will accelerate the absorption of hematoma and improve patients' functional outcomes. Results of this study can potentially bring into account new means to improve the outcomes of ICH patients.
Status | Recruiting |
Enrollment | 452 |
Est. completion date | June 30, 2023 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Age = 18 and = 80 years 2. The diagnosis of supratentorial ICH is confirmed by brain CT scan 3. Hematoma volume of 10 to 30 ml and Glasgow Coma Score (GCS)>8 at randomization. 4. National Institutes of Health Stroke Scale (NIHSS)=6 and =20 points at randomization. 5. Randomization and starting treatment between 24 and 48 hours of symptom ictus. 6. Signed and dated informed consent is obtained. Exclusion Criteria: 1. Planned surgical evacuation of ICH prior to administration of investigational intervention 2. ICH concomitant with subarachnoid hemorrhage or intraventricular hemorrhage 3. Suspected secondary ICH related to tumor, ruptured aneurysm or arteriovenous malformation, hemorrhagic transformation of an ischemic infarct, or venous sinus thrombosis 4. Patients with a pre-existing neurological deficit (mRS>1) or psychiatric disease that would confound the neurological or functional evaluations. 5. Coagulopathy - defined as elevated aPTT or INR >1.3 upon presentation; concurrent use of direct thrombin inhibitors (such as dabigatran), direct factor Xa inhibitors (such as rivaroxaban or apixaban), or low-molecular-weight heparin 6. Severe renal disease (i.e., renal disorder requiring dialysis ) or eGFR <30ml/min/1.73m2 7. Severe liver disorder, or ALT >3 times or bilirubin >2 times upper limit of normal 8. Known severe hearing loss or cognitive impairment 9. Known pregnancy, or positive pregnancy test, or breastfeeding 10. Patients known or suspected of not being able to comply with the study protocol due to alcoholism, noncompliance or any other cause 11. Life expectancy of less than 90 days due to co-morbid conditions 12. Concurrent participation in another research protocol for investigation of another experimental therapy 13. Severe, sustained hypertension (Systolic blood pressure> 180 mmHg or diastolic blood pressure> 110 mmHg). 14. Contraindication for remote ischemic conditioning: severe soft tissue injury, fracture, or peripheral vascular disease in the upper limbs. 15. Any condition which, in the judgement of the investigator, might increase the risk to the patient. |
Country | Name | City | State |
---|---|---|---|
China | Beijing Red Cross Emergency Rescue Center | Beijing | Beijing |
China | Beijing Renhe Hospital | Beijing | Beijng |
China | Xuanwu Hospital, Capital Medical University | Beijing | Beijing |
China | The First People's Hospital of Changzhou | Changzhou | Jiangsu |
China | Chengde Central Hospital | Chengde | Hebei |
China | The Six People's Hospital of Hengshui | Hengshui | Hebei |
China | Jiaxing Second Hospital | Jiaxing | Zhejiang |
China | Nanshi Hospital of Nanyang | Nanyang | Henan |
China | Shaoxing People's Hospital | Shaoxing | Zhejiang |
China | Tianjin Huanhu Hospital | Tianjin | Tianjin |
China | Tongliao Municipal Hosptial | Tongliao | Inner Mongolia Autonomous Region |
China | The Affiliated Hospital of Xuzhou Medical University | Xuzhou | Jiangsu |
China | Zhuji People's Hospital of Zhejaing Province | Zhuji | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
Capital Medical University |
China,
Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, Scott PA, Selim MH, Woo D; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015 Jul;46(7):2032-60. doi: 10.1161/STR.0000000000000069. Epub 2015 May 28. — View Citation
Shoamanesh A, Patrice Lindsay M, Castellucci LA, Cayley A, Crowther M, de Wit K, English SW, Hoosein S, Huynh T, Kelly M, O'Kelly CJ, Teitelbaum J, Yip S, Dowlatshahi D, Smith EE, Foley N, Pikula A, Mountain A, Gubitz G, Gioia LC. Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020. Int J Stroke. 2021 Apr;16(3):321-341. doi: 10.1177/1747493020968424. Epub 2020 Nov 11. — View Citation
Zhao W, Jiang F, Li S, Liu G, Wu C, Wang Y, Ren C, Zhang J, Gu F, Zhang Q, Gao X, Gao Z, Song H, Ma Q, Ding Y, Ji X; RICH-1 Investigators. Safety and efficacy of remote ischemic conditioning for the treatment of intracerebral hemorrhage: A proof-of-concept randomized controlled trial. Int J Stroke. 2022 Apr;17(4):425-433. doi: 10.1177/17474930211006580. Epub 2021 Apr 7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Changes of intracerebral hematoma volume | Intracerebral hematoma volume (ml) is assessed by CT brain scan | 0-7 days after enrollment. | |
Other | Changes of perihematomal edema volume | Perihematomal edema volume (ml) is assessed by CT brain scan | 0-7 days after enrollment. | |
Other | Ordinal Distribution of Scores on mRS at Day 90 | The overall ordinal distribution of scores on mRS at 90 days in all subjects of two groups will be determined. | 90 days | |
Other | Ordinal Distribution of Scores on mRS at Day 180 | The overall ordinal distribution of scores on mRS at 180 days in all subjects of two groups will be determined. | 180 days | |
Primary | Proportion of Patients With Modified Rankin Scale (mRS) Score 0-2 at 90 Days | The mRS ranges from 0 to 6, with higher scores indicating worse outcome. The primary outcome measure is the mRS score, dichotomized to define favorable functional outcome as mRS 0-2 at 90 days. | 0-90 days. | |
Secondary | Proportion of Patients With mRS Score 0-3 at 90 Days | The mRS ranges from 0 to 6, with higher scores indicating worse outcome. Another measure of efficacy is the mRS score, dichotomized to define good functional outcome as mRS 0-3 at 90 days. | 90 days | |
Secondary | Proportion of Patients With mRS Score 0-2 at 180 Days | The mRS ranges from 0 to 6, with higher scores indicating worse outcome. Another measure of efficacy is the mRS score, dichotomized to define good functional outcome as mRS 0-2 at 180 days. | 180 days | |
Secondary | Proportion of Patients With mRS Score 0-3 at 180 Days | The mRS ranges from 0 to 6, with higher scores indicating worse outcome. Another measure of efficacy is the mRS score, dichotomized to define good functional outcome as mRS 0-3 at 180 days. | 180 days | |
Secondary | Number of Subjects Experiencing Serious Adverse Events | Number of subjects experiencing Serious adverse events at any time from randomization through day 90 | 90 days | |
Secondary | Number of Subjects With Serious Adverse Events Within 7 Days | Number of Subjects Experiencing Serious Adverse Events within 7 days of randomization | 7 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Enrolling by invitation |
NCT06074081 -
Comparison of 4-weeks of Motor Relearning Program and Mirror Therapy in Improving Upper Limb Motor Function in Stroke Patients.
|
N/A | |
Terminated |
NCT04039178 -
Efficacy of EMF BCI Based Device on Acute Stroke
|
N/A | |
Completed |
NCT04521634 -
Glycaemic Variability in Acute Stroke
|
||
Completed |
NCT03477188 -
The Effects of Somatosensory and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke.
|
N/A | |
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT02677415 -
Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment
|
N/A | |
Recruiting |
NCT01541163 -
Heart and Ischemic STrOke Relationship studY
|
N/A | |
Completed |
NCT01210729 -
Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT00785343 -
Study of Robot-assisted Arm Therapy for Acute Stroke Patients
|
Phase 1 | |
Completed |
NCT04779710 -
How Does Dysphagia Assessment in Acute Stroke Affect Pneumonia?
|
||
Active, not recruiting |
NCT03635749 -
Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis
|
Phase 3 | |
Recruiting |
NCT06149754 -
BraiN20® Monitoring in Acute Stroke Undergoing Thrombectomy
|
||
Recruiting |
NCT04491695 -
Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke
|
Phase 2/Phase 3 | |
Recruiting |
NCT04283760 -
Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients
|
||
Recruiting |
NCT05454397 -
A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients
|
||
Completed |
NCT04488692 -
Early Functional Training in Acute Stroke Inpatient Ward
|
N/A | |
Recruiting |
NCT04214522 -
Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients
|
||
Not yet recruiting |
NCT04157231 -
Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
|
N/A | |
Recruiting |
NCT05469438 -
IMAS Optimization and Applicability in an Acute Stroke Setting.
|